Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.
Check against the official notice below — it lists the full affected range.
Golden State Medical Supply Inc. is recalling Enalapril Maleate Tablets, USP 2.5 mg in bottles of 90 tablets due to Current Good Manufacturing Practice (CGMP) deviations. The recalled product was manufactured by Taro Pharmaceutical Industries, Ltd. and packaged by GSMS, Incorporated in California. Approximately 1,471 bottles were distributed nationwide across Pennsylvania, Massachusetts, Ohio, Texas, Illinois, North Dakota, and Hawaii.
The recall affects multiple lot numbers with expiration dates ranging from June 2022 to November 2023. The affected lot numbers are GS028301, GS029973, GS029974, GS031436, GS031715, GS033191, GS033940, GS034212, GS035315, GS035945, GS036905, GS038038, GS039199, GS039200, and GS040149 (NDC 60429-183-90). The recall record does not specify a remedy or recommended action for affected consumers.
Written by software from the official notice below. Not reviewed by a lawyer.
CGMP Deviations
Reason for recall: CGMP Deviations Distribution: Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI Quantity: 1,471 bottles Lot/code info: Lots: GS028301, 2.5 mg; 90 tablets, Exp.: 06/2022; Lots: GS029973, GS029974, GS031436, GS031715, GS033191, GS033940, Exp. : 10/2022; Lot: GS034212, Exp.: 12/2022; Lot: GS035315, GS035945, GS036905, GS038038, GS039199, Exp.: 04/2023; Lot: GS039200, GS040149, Exp.: 11/2023. (NDC: 60429-183-90).
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.